AMY GREENBERG: Open Payments
NPI 1326071986 · MIRAMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,913 in 131 payments from 17 companies in 2025. Trend: 2023 $1,473 · 2024 $1,854 · 2025 $2,913
Food & beverage: $1,998Consulting: $900Education: $15
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 57 | $1,408 |
| ABBVIE INC. | 23 | $303 |
| Regeneron Healthcare Solutions, Inc. | 12 | $263 |
| GENZYME CORPORATION | 7 | $228 |
| Novartis Pharmaceuticals Corporation | 6 | $149 |
| Lilly USA, LLC | 4 | $105 |
| PFIZER INC. | 4 | $88 |
| Galderma Laboratories, L.P. | 4 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, EBGLYSS, COSENTYX, CIBINQO, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
